Mikael Dolsten

Mikael Dolsten, M.D., Ph.D. is President of Pfizer Worldwide Research and Development (WRD) and Executive Vice President of Pfizer, Inc., advancing the company’s scientific leadership across therapeutic areas designed to bring forward therapies that significantly improve people’s lives. He is a member of the Pfizer Executive Leadership Team and co-chairs the company’s Portfolio Strategy and Investment Committee.

“I am proud to be part of a team that has revamped R&D at Pfizer to deliver greater value for patients, shareholders and the communities we serve.”